PRIMARY HYPEROXALURIA TYPE 1
Clinical trials for PRIMARY HYPEROXALURIA TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new PRIMARY HYPEROXALURIA TYPE 1 trials appear
Sign up with your email to follow new studies for PRIMARY HYPEROXALURIA TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare kidney disease: experimental drug YOLT-203 enters phase 2 trial
Disease control Not yet recruitingThis study tests an experimental drug, YOLT-203, in 36 children and adults with primary hyperoxaluria type 1 (PH1), a rare genetic condition that causes painful kidney stones and kidney damage. The goal is to see if a single dose can safely lower oxalate levels in urine and blood…
Matched conditions: PRIMARY HYPEROXALURIA TYPE 1
Phase: PHASE2 • Sponsor: YolTech Therapeutics Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New blood test could help kidney patients in israel
Knowledge-focused Not yet recruitingThis study aims to validate a blood test for measuring oxalate levels, which is currently not available in Israel. Researchers will compare results from a local lab with an external lab using 50 blood samples. They will also explore how vitamin C levels relate to oxalate in patie…
Matched conditions: PRIMARY HYPEROXALURIA TYPE 1
Sponsor: Western Galilee Hospital-Nahariya • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC